CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
Completed
Nabi Biopharmaceuticals
Phase 4
2005-01-01
The purpose of the study is to evaluate the effects of two phosphate binders, PhosLo and
sevelamer, on heart calcification in dialysis patients. The study will use a non-invasive
technique, electron beam computed tomography (CT) scanning, to measure calcium in the
coronary arteries, the aortic valve, and the mitral valve.
EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
Completed
Nabi Biopharmaceuticals
Phase 3
2005-05-01
The purpose of this study is to determine if calcium acetate (PhosLo) can control serum
phosphorus in pre-dialysis patients with moderate to severe impairment of kidney function.
Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
Completed
Fresenius Medical Care North America
Phase 1
2008-08-01
To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in
healthy volunteers with calcium citrate as a positive control.
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Completed
Collaborative Study Group (CSG)
Phase 3
2010-05-01
This is a research study for people with high blood phosphorus levels who are on dialysis.
This medical condition can cause weakening of the bones and damage other organs. This can
lead to many health problems, and sometimes death. Phosphorus is in much of the food we eat,
and is helpful to us in small amounts. Patients with kidney failure have trouble getting rid
of the phosphorus eaten in food. Dialysis can help remove some of the phosphorus, but often
patients must take a phosphate binder like PhosLo®, Renagel®, or Renvela® to bring the blood
phosphorus levels back to normal. The purpose of this study is to see if KRX-0502 (ferric
citrate) is safe and effective as a phosphate binder.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.